Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Mirogabalin

Mirogabalin (DS5565) is a selective α2δ-1 ligand calcium channel blocker developed for its analgesic properties. It is utilized in research on neuropathic pain models, with studies demonstrating efficacy in both in vitro binding assays and in vivo animal models of chronic pain.

Product Specifications

CAS Number

1138245-13-2

Product Name Alternative

DS-5565, DS5565, DS 5565, CalciumChannel, Ca channels, Ca2+ channels, Calcium Channel, inhibit, Mirogabalin, Inhibitor, α2δ calcium channels

Field of Research

Metabolism Research, Pharmacology & Drug Discovery

Purity

98.57% (May vary between batches)

Solubility

DMSO:1.83 mg/mL (8.74 mM)

Smiles

CCC1=C[C@@H]2[C@@H] (C[C@]2 (CN) CC (O) =O) C1

Molecular Formula

C12H19NO2

Molecular Weight

209.28

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

Amisulpride-d5 Hydrochloride
CS-O-06402 1 Each

Amisulpride-d5 Hydrochloride

Sign In for Pricing
View Details
DIP2C (NM_014974) Human Tagged ORF Clone
RC209325 10 µg

DIP2C (NM_014974) Human Tagged ORF Clone

Sign In for Pricing
View Details
Recombinant Human Proteasome subunit beta type-7 (PSMB7), partial
CSB-RP013454h-01 10 µg

Recombinant Human Proteasome subunit beta type-7 (PSMB7), partial

Sign In for Pricing
View Details
Recombinant Human Proteasome subunit beta type-7 (PSMB7), partial
CSB-RP013454h-02 50 µg

Recombinant Human Proteasome subunit beta type-7 (PSMB7), partial

Sign In for Pricing
View Details
Recombinant Human Proteasome subunit beta type-7 (PSMB7), partial
CSB-RP013454h-03 200 µg

Recombinant Human Proteasome subunit beta type-7 (PSMB7), partial

Sign In for Pricing
View Details
Recombinant Human Proteasome subunit beta type-7 (PSMB7), partial
CSB-RP013454h-04 500 µg

Recombinant Human Proteasome subunit beta type-7 (PSMB7), partial

Sign In for Pricing
View Details